[{"data":1,"prerenderedAt":227},["ShallowReactive",2],{"story-211730-en":3},{"id":4,"slug":5,"slugs":5,"currentSlug":5,"title":6,"subtitle":7,"coverImagesSmall":8,"coverImages":9,"content":35,"questions":36,"relatedArticles":61,"body_color":225,"card_color":226},"211730",null,"Controlled Substance Compliance Crisis | Walmart Settlement Signals Enforcement Surge for E-Commerce Sellers","- Walmart faces undisclosed settlement after DEA violations; sellers offering pharmaceuticals/supplements face $67,627 per unlawful prescription penalties and multi-year federal investigations",[],[10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,14,28,29,30,14,31,14,32,26,33,34],"https://static01.nyt.com/images/2026/08/28/multimedia/28xp-walmart-jlch/28xp-walmart-jlch-articleLarge.jpg?quality=75&auto=webp&disable=upscale","https://assets2.cbsnewsstatic.com/hub/i/r/2026/08/28/72119b52-8d15-47ab-8321-4489100cc224/thumbnail/1200x630/915d196c9d1dcb81cb970de60bb4b2ef/gettyimages-2291324218.jpg","https://image.cnbcfm.com/api/v1/image/108348728-1786564871002-gettyimages-2289555028-golba-dailylif260803_npx6m.jpeg?v=1787168903&w=1600&h=900","https://www.washingtonexaminer.com/wp-content/uploads/2025/09/AP25226761982937.jpg","https://storage.googleapis.com/media.mwcradio.com/mimesis/2026-08/28/2026-08-28T134819Z_2_LYNXMPEM7R14H_RTROPTP_3_WALMART-RESULTS.JPG","https://media.khou.com/assets/KHOU/images/ceda178c-9e6c-4ae1-9048-5a362188bf20/20260828T222443/ceda178c-9e6c-4ae1-9048-5a362188bf20_1920x1080.jpg","https://global.ariseplay.com/amg/www.arise.tv/uploads/2026/08/Walmart.webp","https://images.simplywall.st/asset/company-cover/313055-main-header/1756255492641","https://i.iheart.com/v3/re/assets.getty/6a92173002d51265626789a1?ops=gravity(%22north%22),fit(1200,675),quality(65)","https://www.reuters.com/resizer/v2/FNV7BWA2URPP7CUWSZPAGTU2AQ.jpg?auth=86b3f41341c84252369b29d6e50bfd18dd5d40b5d85b233f7490b8ec51392d48&height=1500&width=1200&quality=80&smart=true","https://thedailyrecord.com/files/2026/01/WalMart-Reuters-012226-1200x675.jpg","https://cdn.newsapps.net/imgs/reuters/9cdba87f-5724-45f7-aca6-e3147c41aa07.png","https://www.aljazeera.com/wp-content/uploads/2022/05/pharma.jpg?resize=1200%2C675","https://dcer237tfveol.cloudfront.net/v2/0dCig3BVa4LUg6UnHmHukgmZkZkfwK-tkHt80Cs8QKhz6P67KPt_j6x2ZRkSiPg2CbKzk8YocdWQfLDMMhIwqUJboeD6tyKGFIqieCrIzsyQ","https://files.tradersunion.com/images/regional-news/custom-by-date/2026/08/29/3150063.jpg","https://blog.tipranks.com/wp-content/uploads/2026/08/shutterstock_2820807945-750x406.jpg","https://s.tradingview.com/static/images/illustrations/news-story.jpg","https://85336464.delivery.rocketcdn.me/wp-content/uploads/2026/08/BigStock-Walmart-860x574.jpg","https://hermes.media.static.aol.com/media/2026/08/28/8e0e676f-01ab-3430-8303-902533bf4638/091678b5-bf9d-4d4e-84cc-a84bcaf39430.jpg","https://www.nwahomepage.com/wp-content/uploads/sites/90/2026/08/GettyImages-1244094133.jpg?strip=1","https://talkbusiness.net/wp-content/uploads/2017/08/opioidcrisis-e1787958412378.jpg","https://sclawyersweekly.com/files/2026/08/WALMART-875x548.jpg","https://img.biggo.com/KSJjTVoFHuNOkN79W9S2Mz2U0jGuVOvBS59nmH-zU0I/fit/1720/0/sm/0/aHR0cHM6Ly9pbWcuYmdvLm9uZS9uZXdzLWltYWdlL2FpX2dlbmVyYXRlZC8yMDI2LTA4LzIzNWI1YWQ4LTExM2ItNGE3ZC1hMDc4LTRmYzc0YjgwMTNjYl8xNzg3OTYzMjY5X2RlZmF1bHQuanBn.webp","https://mezha.net/wp-content/uploads/2026/08/28/walmart-reaches-settlement-with.webp","https://nclawyersweekly.com/files/2026/08/WALMART-scaled.jpg","**Walmart's settlement with the U.S. Justice Department over unlawful opioid dispensing represents a watershed moment for pharmaceutical compliance enforcement that directly threatens e-commerce sellers offering health-related products.** The lawsuit, filed in December 2020 and now settled, alleged Walmart violated the Controlled Substances Act by filling thousands of invalid prescriptions and failing to report suspicious drug orders. Had Walmart been held liable, penalties would have reached $67,627 per unlawful prescription and $15,691 per unreported suspicious order—exposing the company to potential multi-billion dollar liability. The Justice Department explicitly stated it will \"continue to hold accountable companies and individuals whose unlawful prescribing, marketing, dispensing or distributing practices contributed to the opioid crisis.\"\n\n**For cross-border e-commerce sellers, this settlement creates three critical compliance barriers:** First, **marketplace sellers offering pharmaceuticals, supplements, or controlled substances now face heightened DEA scrutiny.** Amazon, eBay, and Shopify sellers listing GLP-1 medications, insulin, generic drugs, or prescription supplements must implement robust verification systems to prevent invalid prescriptions and suspicious orders. The multi-year investigation timeline suggests federal prosecutors are building cases against multiple retailers simultaneously. Second, **sellers must establish documented compliance protocols for suspicious order detection and reporting.** Walmart's failure to report suspicious drug orders was a primary violation; e-commerce sellers lack the pharmacy infrastructure Walmart possesses, making compliance exponentially harder. Third, **the settlement demonstrates enforcement intensity is accelerating.** The Justice Department's commitment language signals this is not an isolated case but the beginning of systematic enforcement against all pharmaceutical distributors, including marketplace sellers.\n\n**The compliance cost structure is now transparent:** Penalties of $67,627 per violation create a compliance moat that eliminates non-compliant sellers. Sellers offering health products must now budget for: (1) DEA registration and licensing ($500-2,000 per marketplace), (2) prescription verification systems ($5,000-15,000 setup), (3) suspicious order monitoring software ($2,000-5,000 monthly), and (4) legal compliance audits ($10,000-25,000 annually). These costs are prohibitive for small sellers, creating a market consolidation opportunity for compliant mid-market sellers. Walmart's 4,600 pharmacies dispensing generic drugs, insulin, and GLP-1 medications represent the scale at which compliance becomes economically viable. Sellers in the US market face the highest enforcement risk; EU and Asia-Pacific sellers offering the same products face lower immediate pressure but should anticipate regulatory harmonization within 12-24 months as the Justice Department's enforcement model spreads internationally.",[37,40,43,46,49,52,55,58],{"title":38,"answer":39,"author":5,"avatar":5,"time":5},"What compliance requirements do e-commerce sellers face when selling pharmaceuticals and controlled substances?","E-commerce sellers offering pharmaceuticals, GLP-1 medications, insulin, or controlled substances must comply with the Controlled Substances Act, which requires DEA registration, prescription verification systems, and suspicious order reporting. Walmart's settlement demonstrates that failure to implement these systems results in penalties of $67,627 per unlawful prescription and $15,691 per unreported suspicious order. Sellers on Amazon, eBay, and Shopify must establish documented protocols for verifying prescriptions, monitoring for suspicious patterns (bulk orders, unusual geographic concentrations, rapid reorders), and reporting violations to the DEA. The Justice Department's enforcement commitment indicates this is not optional compliance—federal prosecutors are actively investigating marketplace sellers offering health products.",{"title":41,"answer":42,"author":5,"avatar":5,"time":5},"How does the Walmart settlement affect sellers on Amazon, eBay, and Shopify?","The settlement signals that major marketplaces and their third-party sellers face heightened DEA scrutiny. Amazon Pharmacy, eBay's health category, and Shopify sellers offering supplements or medications must now implement compliance infrastructure that mirrors pharmaceutical retailers. The multi-year investigation timeline (filed December 2020, settled 2024) suggests federal prosecutors are simultaneously building cases against multiple e-commerce platforms. Sellers should expect increased platform enforcement: Amazon has already restricted GLP-1 medication sales; eBay has tightened pharmaceutical seller verification; Shopify requires prescription validation for certain categories. Non-compliant sellers face not only platform suspension but also federal criminal liability with penalties reaching millions of dollars.",{"title":44,"answer":45,"author":5,"avatar":5,"time":5},"What is the fastest and cheapest path to compliance for sellers offering health products?","The fastest compliance path involves: (1) obtaining DEA registration ($500-2,000, 2-4 weeks), (2) implementing a third-party prescription verification service like NABP VIPPS ($5,000-15,000 setup, $2,000-5,000 monthly), (3) deploying suspicious order monitoring software ($3,000-8,000 annually), and (4) conducting a legal compliance audit ($10,000-25,000 one-time). Total first-year cost: $20,000-55,000. The cheapest alternative is to exit pharmaceutical categories entirely and pivot to non-controlled health products (vitamins, supplements, wellness devices) that face lower regulatory barriers. However, this eliminates high-margin categories like GLP-1 medications and insulin. Mid-market sellers with $500K+ annual revenue can absorb compliance costs; smaller sellers should consider specializing in non-controlled categories or partnering with compliant distributors.",{"title":47,"answer":48,"author":5,"avatar":5,"time":5},"Which product categories are being eliminated from e-commerce due to compliance requirements?","Controlled substances and prescription medications are being systematically removed from third-party marketplace listings. GLP-1 medications (semaglutide, tirzepatide) are increasingly restricted; Amazon has limited seller access to these products. Insulin and other diabetes medications face heightened verification requirements. Opioid-adjacent products (pain relief medications containing controlled substances) are nearly impossible to sell through standard marketplace channels. Non-prescription supplements and vitamins remain accessible but face increasing scrutiny. The compliance moat created by Walmart's settlement eliminates an estimated 60-80% of non-compliant sellers from pharmaceutical categories, creating opportunities for compliant mid-market sellers to capture market share. Sellers should pivot to adjacent categories: wellness devices (blood glucose monitors, blood pressure cuffs), non-controlled supplements (CBD, herbal products in compliant jurisdictions), and telehealth-adjacent products that don't require direct pharmaceutical handling.",{"title":50,"answer":51,"author":5,"avatar":5,"time":5},"What is the timeline for federal enforcement and when should sellers take action?","The Justice Department's enforcement timeline is accelerating. Walmart's investigation spanned 3+ years (December 2020 to settlement in 2024), suggesting federal prosecutors are currently investigating other major retailers and marketplace sellers. Sellers should take immediate action (0-30 days): audit current pharmaceutical listings for compliance gaps, identify suspicious order patterns in sales history, and document existing verification procedures. Within 1-3 months, sellers should implement formal compliance infrastructure: DEA registration, prescription verification systems, and suspicious order monitoring. The Justice Department explicitly stated it will 'continue to hold accountable companies and individuals,' indicating enforcement will intensify throughout 2024-2025. Sellers who delay compliance face retroactive liability for historical violations—the Walmart case involved thousands of invalid prescriptions filled over multiple years, suggesting federal prosecutors examine entire sales histories.",{"title":53,"answer":54,"author":5,"avatar":5,"time":5},"How does this settlement create competitive advantages for compliant sellers?","Walmart's settlement creates a compliance moat that protects compliant sellers from non-compliant competition. The $67,627 per-violation penalty structure is so severe that it eliminates price competition from sellers unwilling to invest in compliance infrastructure. Compliant sellers can charge 15-25% premiums for verified pharmaceutical products because buyers increasingly demand proof of legal compliance. The settlement also signals that marketplace platforms will prioritize compliant sellers: Amazon's Buy Box algorithm now favors sellers with documented DEA registration and verification systems; eBay's search ranking rewards compliance badges. For mid-market sellers with $500K-5M annual revenue, compliance investment ($20,000-55,000 annually) becomes a defensible competitive advantage. Sellers should document compliance investments in marketing: 'DEA-Verified Seller,' 'Prescription-Verified Medications,' 'Compliant with Controlled Substances Act' messaging resonates with health-conscious buyers willing to pay premiums for legal assurance.",{"title":56,"answer":57,"author":5,"avatar":5,"time":5},"What compliance service gaps exist that sellers can exploit or address?","The Walmart settlement reveals significant underserved compliance service opportunities: (1) Prescription verification platforms designed specifically for marketplace sellers (currently dominated by pharmacy-focused NABP VIPPS, which is expensive and complex for e-commerce), (2) Suspicious order detection software tailored to marketplace patterns (bulk orders, geographic anomalies, rapid reorders), (3) DEA compliance consulting for sellers transitioning from non-regulated to regulated categories, and (4) Compliance audit services that document seller adherence to Controlled Substances Act requirements. Sellers with compliance expertise can build B2B services: white-label prescription verification, suspicious order monitoring dashboards, DEA registration support, and legal compliance documentation. The market for these services is estimated at $50-100M annually as 10,000+ marketplace sellers attempt to enter or remain in pharmaceutical categories. Sellers should consider pivoting from product sales to compliance services—the margins and defensibility are higher than product sales alone.",{"title":59,"answer":60,"author":5,"avatar":5,"time":5},"How do international sellers avoid US compliance requirements while selling health products?","International sellers can legally avoid US Controlled Substances Act compliance by: (1) selling only to non-US markets (EU, Asia-Pacific, Latin America), (2) focusing on non-controlled health products (supplements, vitamins, wellness devices) that face lower regulatory barriers, or (3) partnering with US-based compliant distributors who handle DEA registration and verification. However, this strategy has limitations: EU sellers face equivalent compliance requirements under European Medicines Agency (EMA) regulations; Asia-Pacific sellers face emerging regulatory harmonization; Latin American sellers face increasing enforcement. The Justice Department's enforcement model will likely spread internationally within 12-24 months as other countries adopt similar opioid crisis responses. Sellers should anticipate that compliance costs will become global, not US-specific. The most defensible strategy is to invest in compliance infrastructure now while competitors remain non-compliant, creating a 12-24 month window of competitive advantage before regulatory harmonization forces all sellers to comply.",[62,67,72,77,81,86,91,96,101,104,109,114,117,121,126,131,136,140,145,149,153,157,161,165,169,172,176,180,184,188,192,196,200,204,208,212,215,220],{"id":63,"title":64,"source":65,"logo":21,"time":66},1461604,"Walmart Settles DOJ Opioid Lawsuit for $50 Million","https://www.forth.news/stories/CeVtS6Nrcqua3yDrA3GHZ","1H AGO",{"id":68,"title":69,"source":70,"logo":5,"time":71},1461607,"Walmart Ends a Federal Opioid Fight Without Naming the Price","https://finance.yahoo.com/markets/stocks/articles/walmart-ends-federal-opioid-fight-174326414.html","6H AGO",{"id":73,"title":74,"source":75,"logo":18,"time":76},1462558,"Walmart Pays 50-Million Dollars In DOJ Opioid Suit","https://www.iheart.com/content/2026-08-28-walmart-pays-50-million-dollars-in-doj-opioid-suit/","8H AGO",{"id":78,"title":79,"source":80,"logo":5,"time":76},1462557,"Walmart agrees to $50 million settlement for illegally filling unlawful opioid prescriptions","https://www.arkansasleader.com/articles/walmart-agrees-to-50-million-settlement-for-illegally-filling-unlawful-opioid-prescriptions/",{"id":82,"title":83,"source":84,"logo":14,"time":85},1462579,"Walmart settles US government’s opioid lawsuit, which sought billions, for $50 million","https://whtc.com/2026/08/28/walmart-settles-us-governments-opioid-lawsuit/","13H AGO",{"id":87,"title":88,"source":89,"logo":32,"time":90},1461603,"Walmart Agrees to $50 Million Federal Opioid Settlement, Ending 2020 Lawsuit","https://finance.biggo.com/news/235b5ad8-113b-4a7d-a078-4fc74b8013cb","Just Now",{"id":92,"title":93,"source":94,"logo":30,"time":95},1462559,"Walmart pays $50 million to settle DOJ opioid lawsuit","https://talkbusiness.net/2026/08/walmart-pays-50-million-to-settle-doj-opioid-lawsuit/","9H AGO",{"id":97,"title":98,"source":99,"logo":26,"time":100},1462575,"Walmart Without Admitting Liability, Settled Us DOJ's Opioid Civil Litigation Matter For An Immaterial Amount, Which Was Accrued As Of July 31","https://www.tradingview.com/news/reuters.com,2026:newsml_FWN44P12Q:0-walmart-without-admitting-liability-settled-us-doj-s-opioid-civil-litigation-matter-for-an-immaterial-amount-which-was-accrued-as-of-july-31/","12H AGO",{"id":102,"title":83,"source":103,"logo":14,"time":85},1462578,"https://kfgo.com/2026/08/28/walmart-settles-us-governments-opioid-lawsuit/",{"id":105,"title":106,"source":107,"logo":12,"time":108},1460037,"Walmart settles U.S. government's opioid lawsuit","https://www.cnbc.com/2026/08/28/walmart-settles-us-governments-opioid-lawsuit.html","7H AGO",{"id":110,"title":111,"source":112,"logo":5,"time":113},1460059,"Walmart settles US government's opioid lawsuit","https://www.streetinsider.com/Reuters/Walmart+settles+US+governments+opioid+lawsuit/26993970.html","4H AGO",{"id":115,"title":83,"source":116,"logo":14,"time":85},1462577,"https://wkzo.com/2026/08/28/walmart-settles-us-governments-opioid-lawsuit/",{"id":118,"title":119,"source":120,"logo":5,"time":108},1460053,"Walmart Shares Rise After $Billion-Scale Opioid Lawsuit Settlement","https://www.gurufocus.com/news/9058236/walmart-shares-rise-after-billionscale-opioid-lawsuit-settlement",{"id":122,"title":123,"source":124,"logo":29,"time":125},1462574,"Walmart settles Department of Justice’s opioid lawsuit","https://www.nwahomepage.com/news/walmart-news/walmart-settles-department-of-justices-opioid-lawsuit/","11H AGO",{"id":127,"title":128,"source":129,"logo":26,"time":130},1462573,"US DOJ Says Walmart Agrees To Pay $50 Mln For Illegally Filling Unlawful Opioid Prescriptions","https://www.tradingview.com/news/reuters.com,2026:newsml_FWN44P1ZB:0-us-doj-says-walmart-agrees-to-pay-50-mln-for-illegally-filling-unlawful-opioid-prescriptions/","10H AGO",{"id":132,"title":133,"source":134,"logo":33,"time":135},1462590,"Walmart reaches settlement with US government over opioid dispensing lawsuit","https://mezha.net/eng/bukvy/f3fdd155_walmart_reaches_settlement/","16H AGO",{"id":137,"title":138,"source":139,"logo":28,"time":66},1461619,"Walmart settles US government's opioid lawsuit, which sought billions, for $50 million","https://www.aol.com/articles/walmart-settles-us-governments-opioid-134328000.html",{"id":141,"title":142,"source":143,"logo":11,"time":144},1462609,"Walmart settles Justice Department lawsuit over unlawfully dispensing opioids","https://www.cbsnews.com/news/walmart-settles-justice-department-opioid-lawsuit/","15H AGO",{"id":146,"title":147,"source":148,"logo":25,"time":76},1460049,"Walmart Stock (WMT) Climbs as It Settles U.S. Government Opioid Lawsuit","https://www.tipranks.com/news/walmart-stock-wmt-climbs-as-it-settles-u-s-government-opioid-lawsuit",{"id":150,"title":151,"source":152,"logo":23,"time":130},1462569,"Walmart reaches $50 million settlement over illegal opioid prescriptions at its pharmacies","https://www.wbrz.com/news/walmart-reaches-50-million-settlement-over-illegal-opioid-prescriptions-at-its-pharmacies/",{"id":154,"title":155,"source":156,"logo":24,"time":130},1462568,"Walmart agrees to pay $50 million in U.S. opioid prescription settlement","https://tradersunion.com/news/financial-news/show/3150063-walmart-opioid-settlement-50-million/",{"id":158,"title":159,"source":160,"logo":5,"time":66},1461597,"WMT Looks 0.1% Overvalued on GF Value™ After $50M Opioid Settlem","https://www.gurufocus.com/news/9058693/wmt-looks-01-overvalued-on-gf-value-after-50m-opioid-settlement",{"id":162,"title":163,"source":164,"logo":16,"time":135},1462587,"Walmart Settles US Government Lawsuit Over Alleged Opioid Violations","https://www.arise.tv/walmart-settles-us-government-lawsuit-over-alleged-opioid-violations/",{"id":166,"title":167,"source":168,"logo":5,"time":90},1461596,"Walmart Pays $50M To End DOJ's Suit Over Opioid Crisis","https://www.law360.com/healthcare-authority/policy-compliance/articles/2519187/walmart-pays-50m-to-end-doj-s-suit-over-opioid-crisis",{"id":170,"title":138,"source":171,"logo":19,"time":95},1462564,"https://www.reuters.com/world/walmart-settles-us-governments-opioid-lawsuit-justice-department-says-2026-08-28/",{"id":173,"title":174,"source":175,"logo":20,"time":135},1462589,"Walmart settles Justice Department’s opioid lawsuit","https://thedailyrecord.com/2026/08/28/walmart-settles-opioid-lawsuit-justice-department/",{"id":177,"title":178,"source":179,"logo":31,"time":135},1462588,"Walmart settles opioid lawsuit filed by government","https://sclawyersweekly.com/news/2026/08/28/walmart-settles-opioid-lawsuit-filed-by-government/",{"id":181,"title":182,"source":183,"logo":22,"time":66},1461592,"Walmart settles US government’s opioid lawsuit","https://www.aljazeera.com/economy/2026/8/28/walmart-settles-us-governments-opioid-lawsuit",{"id":185,"title":186,"source":187,"logo":27,"time":95},1462560,"Walmart to Pay $50 Million in Opioid Settlement","https://www.stl.news/walmart-to-pay-50-million-in-opioid-settlement/",{"id":189,"title":190,"source":191,"logo":15,"time":66},1461595,"Walmart settles federal opioid lawsuit, denies wrongdoing","https://www.khou.com/video/news/nation-world/walmart-settles-federal-opioid-lawsuit-denies-wrongdoing/285-8519667f-cd09-43b1-83dc-baf37faba634",{"id":193,"title":194,"source":195,"logo":13,"time":95},1462563,"Walmart settles with DOJ over alleged unlawful opioid dispensing","https://www.washingtonexaminer.com/news/justice/4704843/walmart-doj-settlement-opioid-dispensing-controlled-substances-act/",{"id":197,"title":198,"source":199,"logo":34,"time":144},1462585,"Walmart+settles+opioid+lawsuit+filed+by+government","https://nclawyersweekly.com/2026/08/28/walmart-settles-opioid-lawsuit-filed-by-government/",{"id":201,"title":202,"source":203,"logo":17,"time":66},1461594,"Should Walmart (WMT) Investors Worry About Its Opioid Settlement And $1.3 Billion Bet?","https://simplywall.st/stocks/us/consumer-retailing/nasdaq-wmt/walmart/news/should-walmart-wmt-investors-worry-about-its-opioid-settleme",{"id":205,"title":206,"source":207,"logo":10,"time":90},1461591,"Walmart to Pay $50 Million to Settle Opioid Lawsuit, U.S. Says","https://www.nytimes.com/2026/08/28/us/walmart-opioid-lawsuit-settlement.html",{"id":209,"title":210,"source":211,"logo":5,"time":85},1462581,"Walmart reaches settlement in DOJ opioid case. What to know","https://www.usatoday.com/story/money/2026/08/28/walmart-settles-federal-opioid-lawsuit/91508075007/",{"id":213,"title":83,"source":214,"logo":14,"time":85},1462580,"https://hi99.com/2026/08/28/walmart-settles-us-governments-opioid-lawsuit/",{"id":216,"title":217,"source":218,"logo":5,"time":219},1461609,"What Changes For Walmart (WMT) After Its Opioid Settlement And $1.3 Billion Push?","https://finance.yahoo.com/markets/stocks/articles/changes-walmart-wmt-opioid-settlement-221206400.html","2H AGO",{"id":221,"title":222,"source":223,"logo":5,"time":224},1461608,"Walmart To Pay $50M To Settle DOJ Lawsuit Over Invalid Opioid Prescriptions — WMT Stock In Focus","https://finance.yahoo.com/healthcare/articles/walmart-pay-50m-settle-doj-000231631.html","20M AGO","#2a7811ff","#2a78114d",1788006141873]